Slashdot.org

T-Mobile is opening registration today for a beta test of Live Translation, an AI-powered feature that will translate live phone calls into more than 50 languages when it launches this spring. The feature operates at the network level, so it doesn't require any specific app or device -- beta participants simply dial 87 to activate it on a call. T-Mobile President of Technology and CTO John Saw told The Verge that Live Translation works over VoLTE, VoNR and VoWiFi, meaning it isn't limited to 5G. The only requirement is that a T-Mobile customer must initiate the translation. The beta will be free, though T-Mobile has not said whether the feature will eventually be paywalled.

Read more of this story at Slashdot.

An anonymous reader shares a report: The Food and Drug Administration has refused to start a review of Moderna's application for its experimental flu shot, the company announced Tuesday, in another sign of the Trump administration's influence on tightening vaccine regulations in the U.S. Moderna said the move is inconsistent with previous feedback from the agency from before it submitted the application and started phase three trials on the shot, called mRNA-1010. The drugmaker said it has requested a meeting with the FDA to "understand the path forward." Moderna noted that the agency did not identify any specific safety or efficacy issues with the vaccine, but instead objected to the study design, despite previously approving it. The company added that the move won't impact its 2026 financial guidance. Moderna's jab showed positive phase three data last year, meeting all of the trial goals. At the time, Moderna said the stand-alone flu shot was key to its efforts to advance a combination vaccine targeting both influenza and Covid-19.

Read more of this story at Slashdot.